Ignite Creation Date:
2025-12-24 @ 10:33 PM
Ignite Modification Date:
2026-03-11 @ 5:25 PM
Study NCT ID:
NCT02131935
Status:
COMPLETED
Last Update Posted:
2014-05-28
First Post:
2014-05-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Impaired Peripheral Endothelial Function and In-stent Restenosis
Sponsor:
Kumamoto University
Organization:
Study Overview
Official Title:
Impaired Peripheral Endothelial Function as Assessed by Digital Reactive Hyperemia Peripheral Arterial Tonometry and Risk of In-Stent Restenosis
Status:
COMPLETED
Status Verified Date:
2014-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The investigators assessed the hypothesis that whether RH-PAT index (RHI) as a marker of endothelial dysfunction could predict occurrence of ISR after percutaneous coronary intervention (PCI).
Detailed Description:
This is a prospective observational study of all consecutive patients with coronary artery disease (CAD) treated with PCI at Kumamoto University Hospital between January 2010 and September 2012. Inclusion criteria consisted of patients who were symptomatic for myocardial ischemia and who were undergoing stent implantation for significant CAD.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: